Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

St. Jude forecasts 2014 growth in sales and revenue
Yahoo/Reuters
Wednesday, January 22, 2014 - 8:39am
tags:
St. Jude Medical, devices
Abbott revenue misses, hurt by dollar, weak formula sales
Yahoo/Reuters
Wednesday, January 22, 2014 - 8:38am
tags:
Abbott Laboratories, earnings
Torrent Pharma surges; margins driven profit impress street
Yahoo/Reuters
Wednesday, January 22, 2014 - 8:37am
tags:
Torrent Pharmaceuticals
Drug Approvals Take Customized Approach Based on Disease
Bloomberg
Wednesday, January 22, 2014 - 8:36am
tags:
drug approvals
Merck KGaA Says Pharmaceutical Unit Integral to Strategy
Bloomberg
Wednesday, January 22, 2014 - 8:35am
tags:
Merck KGaA
Sanofi’s Aubagio Wins Final Approval From U.K. Cost Agency NICE
Bloomberg
Wednesday, January 22, 2014 - 8:34am
tags:
Sanofi, Aubagio, NICE, MS, multiple sclerosis
Pfizer Finds Success With Chantix Clinical Study
Wall St Cheat Sheet
Wednesday, January 22, 2014 - 8:32am
tags:
Pfizer, Chantix, clinical studies
Quality Of Evidence Used By FDA To Approve New Drugs Varies Widely
Forbes
Wednesday, January 22, 2014 - 8:25am
tags:
FDA, drug approvals
Abbott Faces New Trial Over Gay Juror Exclusion in HIV drug pricing trial
Bloomberg
Tuesday, January 21, 2014 - 3:11pm
tags:
Abbott Labs, GSK, HIV
J&J Stock Falls Most in 5 Months on 2014 Profit Forecast
Bloomberg
Tuesday, January 21, 2014 - 3:10pm
tags:
JNJ
Will Pfizer Stop-Smoking Pill Hurt Tobacco Giants?
Yahoo/24-7 Wall St
Tuesday, January 21, 2014 - 12:47pm
tags:
Pfizer, smoking cessation, tobacco
Mallinckrodt Up on FDA Approval
Yahoo/Zacks.com
Tuesday, January 21, 2014 - 12:46pm
tags:
Mallinckrodt, FDA, Pennsaid, osteoarthritis of the knee
Merck to Bristol-Myers Face More Threats on India Patents
Bloomberg
Tuesday, January 21, 2014 - 12:45pm
tags:
Merck, India, Bristol-Myers Squibb, emerging markets
Despite Earnings Beat Johnson & Johnson Shares Sag Thanks To Modest 2014 Outlook
Forbes
Tuesday, January 21, 2014 - 10:11am
tags:
JNJ, earnings
What FDA’s social media guidance means for pharmas
Manhattan Research
Tuesday, January 21, 2014 - 10:07am
tags:
social media, FDA
Athersys, Inc. And The Future Of Regenerative Medicine
Seeking Alpha
Tuesday, January 21, 2014 - 9:43am
tags:
Athersys, regenerative medicine
Eli Lilly: 2014 Predictions
Seeking Alpha
Tuesday, January 21, 2014 - 9:42am
tags:
Eli Lilly, dulaglutide, empagliflozin, solanzemab, ramucirumab, Evista, Gemzar
Will Cubist Pharma (CBST) Miss Earnings?
Yahoo/Zacks.com
Tuesday, January 21, 2014 - 9:40am
tags:
Cubist Pharmaceuticals, earnings
It's Hard to Believe, but Biotech Stocks Are Starting 2014 Hotter Than 2013
TheStreet.com
Tuesday, January 21, 2014 - 9:37am
tags:
biotech, Intercept Pharma, Rexahn, CorMedix, Neurocrine, Cell Therapeutics
Gilead's Sovaldi Hep C Drug Launch Strong
TheStreet.com
Tuesday, January 21, 2014 - 9:35am
tags:
Gilead Sciences, Sovaldi, hepatitis C

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.